Amoy Diagnostics

About:

Amoy Diagnostic focuses on molecular diagnostics for oncology precision medicine.

Website: https://amoydx.com

Twitter/X: AmoyDx

Top Investors: OrbiMed, Qiming Venture Partners

Description:

Amoy Diagnostics is a research and development based diagnostic company focusing on molecular diagnostics for oncology precision medicine. AmoyDx has a portfolio of molecular diagnostic assays. Based on multiple technology platforms including PCR, NGS, FISH and IHC, AmoyDx's core product categories include single gene testing kits, multi-gene testing panels, NGS panels, and NGS analytical systems.

Total Funding Amount:

164M CNY

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Xiamen, Fujian, China

Founded Date:

2008-01-01

Contact Email:

info(AT)amoydx.com

Founders:

Zheng Limou

Number of Employees:

1001-5000

Last Funding Date:

2015-03-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai